Upstream Bioprocessing Flashcards

1
Q

What are the products of traditional bioprocessing?

A
  • Antibiotics
  • Vaccines / viruses
  • Antibodies
  • Recombinant therapeutic proteins (i.e. MAb) (Global market worth £30 billion/year)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the applications for (Stem) Cell bioprocessing?

A
  • Cells and Tissues
  • Banking/Drug screening programmes
  • Larger scale healthcare applications →Stem cell therapies (potential to cure diseases, not just to treat/address symptoms)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe bioprocessing complexity

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Draw a diagtam of therapeutic agent production

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Draw a table of cell requirements

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the INDUSTRIAL SCALE meaning for biotherapeutics

A
  • >10,000 Litres – Monoclonal antibodies (MAbs) and proteins
  • 2,000 Litres – Viral vaccines
  • 50 Litres – Human mesenchymal stem cells for therapies

(Lawson et al, 2017)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Scaled out production

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Scaled Up production

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Advantages of scale-up

A
  • Is the current industrial standard.
  • It is well established.
  • Cost effective.
  • Appropriate for Allogeneic approaches
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Advantages of scale-out

A
  • Allows for parallel runs.
  • In case of contamination or failure, only minimal loss.
  • Appropriate for Autologous approaches.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Disadvantages of Scale up

A
  • Many engineering challenges (e.g. mixing, gradients, temperature and pH maintenance).
  • In case of contamination or failure, maximal loss.
  • Equipment scale challenges.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Disadvantages of scale-out

A
  • Highly laborious unless automation is used.
  • Less cost effective.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the biological and engeineering considerations for scaling up production?

A
  • Scale-up is usually the final step of any R&D programme
  • Biologists usually don’t fully understand the challenges of a scalable process
  • Engineers don’t always understand the biology
  • Engineers don’t get involved soon enough
  • Scaling up a bioprocess requires important engineering aspects that have to be considered early in the process => DETRIMENTAL effect on the overall manufacturing process
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inefficient scale up: Lower economic performance

A
  • Lower yield
  • Lower capacity
  • Lower product quality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Inefficient scale up: Operational instability

A
  • Mechanical instabilities
  • Genetic instability
  • Variability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name some planar culture vessels

A
  • T-flasks
  • Multilayer plates
  • Cell factoreies
  • Roller bottlesCompacT SelectT– automated cell culture platform
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the advantages of planar culture vessels?

A
  • Well accepted and well understood
  • Reproducible and standardised
  • Option to be completely automated (e.g. TAP CompacT SelecT)
18
Q

What are the disadvantages of planar culture vessels?

A
  • Static systems → heterogeneous culture environment (Note: except roller bottles that provide a slightly more homogeneous environment, but with mass and energy transfer gradients)
  • Poor surface area-to-volume ratio
  • Surface limitation and labour intensive →Unfeasible for the production of large cell lot sizes (109/1012 cells)
19
Q

What is a bioreactor?

A

A vessel in which a bio-based process takes place

20
Q

What is a reactor?

A

A vessel in which a chemical reaction takes place

21
Q

Which vessels are cells grown (e.g. bacteria, yeast)?

A

Fermenter

22
Q

Give a brief history of bioreactors

A

•1918 - Biochemist and former Israeli President Chaim Weizmann developed a bacteria fermenter for the production of acetone.

•1944 - De Beeze and Liebmann used the first large scale (>20 litre capacity) fermenter for yeast production.

•1970s – First commercial fermenters, autoclaves, freeze dryers, colony counters were developed.

  • 1980s – First benchtop bioreactor was designed for animal cell culture.
  • 1990s – Microprocessor controlled shakers, provide precision control of set-points, alarms, running time, agitation, pCO2 and temperature.

•2001 – Benchtop system can control up to 4 bioreactors.

2005 – Disposable cell culture flasks.

23
Q

Draw a diagram of bioreactor designs

A
24
Q

Explain how a Pneumatic bioreactor works: Airlift (bubble column)

A
  • Aeration and mixing is achieved by gas sparging
  • Less energy than mechanical stirring
  • Satisfactory heat and mass transfer performance
  • Low shear→ suitable for plant or animal cell culture
  • Absence of any moving parts →reduced contamination and easy maintenance
  • DO and pH control achieved by varying the composition and the rate of the gas flow through the column
  • Challenge: foaming
25
Q

Explain how a Hydraulic bioreactor works: Packed (fixed) /fluidised bed

A
  • Used for immobilised cells in high density cultures intended for protein production in long term cultures
  • Cells grow on macro-porous beads (e.g. glass, ceramic)
  • Mass transfer is achieved by recirculating the medium in a loop for oxygen enrichment
  • Low shear rates, simple medium exchange and cell /product separation
  • As particles are in constant motion, channelling and clogging is avoided (only Fluidised Bed)
  • Non-homogeneous cell distribution (only Fixed Bed), difficult cell harvest.
26
Q

Explain how a Hydraulic bioreactor works: Hollowfibre

A
  • Anchorage-dependent / independent cells
  • Cartridge of capillary-like tubules with perfusable membrane walls
  • Provides a 3D environment for cell growth
  • Enhanced mass transfer
  • Used with hepatocytes as an artificial liver (Bio-Artificial Liver-BAL)
  • Bio-Artificial Kidney – BAK
27
Q

Explain mechanical bioreactor: Stirred Tank (STR)

A
  • Mixing is achieved by mechanical means using an agitator (e.g. impeller)
  • Baffles can be used to reduce vortexing
  • Relatively high input of energy
  • Heating/cooling mantles
  • Gasing options: headspace or purging
  • Multiple impellers improve mixing within tall bioreactors
  • Impellers with different sizes and shapes are used to produce different flow patterns inside the vessel
28
Q

Mixing in STR: flow patterns

A
29
Q

STR: impellers

Rushton

A
  • Radial flow
  • Flat blades
  • Suitable for high cell density cultures (e.g. bacteria, yeast, some fungi)
30
Q

STR: impellers

Pitched-blade

A
  • Flat blades, 45°
  • Simultaneous axial and radial flow
  • Suitable for mammalian cell cultures
31
Q

STR: impellers

Marine

A
  • Axial flow
  • Gentle mixing
  • Suitable for mammalian cells
32
Q

What are the characteristics of microcarriers?

A

Small: to maximize cell culture surface area (high area-to-volume ratio)

Light: to allow easy suspension in culture medium

Density: slightly higher than medium to allow for fast settling when required

Transparent: to allow easy observation of cell attachment and growth

Appropriate surface chemistry: to promote cell attachment

33
Q

Scalable culture systems - microcarriers

A
  • 1st developed microcarrier in 1967 by Van Wezel (dextran-based)
  • Micrometer sized particles made typically from polymers such as polystyrene, modified dextran, gellan
  • Commercially available from multiple manufacturers
  • Different surface chemistries available that determine physico-chemical properties
  • Suitable for adherent-dependent cells
  • Allow cell attachment and proliferation in suspension cultures
  • Increased surface area-to-volume ratio compared to planar systems
34
Q

Name some scalable culture systems - microcarriers

A
  • Plastic (polystyrene)
  • Cytodex 1 (dextran)
  • Collagen
  • Cytopore (gelatin)
  • Hillex II (modifies polystyrene)
  • NUNC 2D MiroHex (polystyrene)
35
Q

Bioreactor operation modes: Batch

A
  • Reactants (nutrients and cells) are introduced at the start of the culture
  • Products are recovered at the end (batch wise)
36
Q

Bioreactor operation modes: FED BATCH / REPEATED

A
  • Reactants are fed semi-regularly (semi-continuously
  • Products are recovered at the end (batch wise)
37
Q

Bioreactor operation modes: CONTINUOUS (PERFUSION):

A
  • Reactor contents is mixed and homogeneous
  • Reactants are fed in and product is removed constantly
  • Volume of the reactor is constant
38
Q

Single use bioreactors

A

Solid trend: disposable bags for media storage, process development, for inoculation, actual bioreactor vessels

39
Q

What are the advanatges of single use bioreactors?

A

Advantage: quicker turn-around times, no steam sterilization or cleaning needed, substantially decreases overall timelines and operational complexity.

40
Q

Single use bioreactors: Two types based on medium agitation

A
  1. Stirrers integrated into the plastic bag
  2. Agitated by a rocking motion (e.g. WAVE bioreactor)
  • Both up to a scale of 1000 Liters volume
  • Both pre-sterilized.